These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12127722)

  • 1. Atherosclerosis: another protein misfolding disease?
    Ursini F; Davies KJ; Maiorino M; Parasassi T; Sevanian A
    Trends Mol Med; 2002 Aug; 8(8):370-4. PubMed ID: 12127722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Misfolding of apoprotein B-100, LDL aggregation and 17-β -estradiol in atherogenesis.
    Brunelli R; De Spirito M; Mei G; Papi M; Perrone G; Stefanutti C; Parasassi T
    Curr Med Chem; 2014; 21(20):2276-83. PubMed ID: 24438526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electronegative low-density lipoprotein. A link between apolipoprotein B misfolding, lipoprotein aggregation and proteoglycan binding.
    Sánchez-Quesada JL; Villegas S; Ordóñez-Llanos J
    Curr Opin Lipidol; 2012 Oct; 23(5):479-86. PubMed ID: 22964994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational changes in apolipoprotein B modulate intracellular assembly and degradation of ApoB-containing lipoprotein particles in HepG2 cells.
    Macri J; Adeli K
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2982-94. PubMed ID: 9409285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LDL phospholipid hydrolysis produces modified electronegative particles with an unfolded apoB-100 protein.
    Asatryan L; Hamilton RT; Isas JM; Hwang J; Kayed R; Sevanian A
    J Lipid Res; 2005 Jan; 46(1):115-22. PubMed ID: 15489541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of apoB-100 secondary structure and conformation in hydroperoxide rich, electronegative LDL(-).
    Parasassi T; Bittolo-Bon G; Brunelli R; Cazzolato G; Krasnowska EK; Mei G; Sevanian A; Ursini F
    Free Radic Biol Med; 2001 Jul; 31(1):82-9. PubMed ID: 11425493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for thermal stability of human low-density lipoprotein.
    Jayaraman S; Gantz D; Gursky O
    Biochemistry; 2005 Mar; 44(10):3965-71. PubMed ID: 15751972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-oxidative modification of native low-density lipoprotein by oxidized low-density lipoprotein.
    Yang M; Leake DS; Rice-Evans CA
    Biochem J; 1996 Jun; 316 ( Pt 2)(Pt 2):377-80. PubMed ID: 8687375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanism for changes in proteoglycan binding on compositional changes of the core and the surface of low-density lipoprotein-containing human apolipoprotein B100.
    Flood C; Gustafsson M; Pitas RE; Arnaboldi L; Walzem RL; Borén J
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):564-70. PubMed ID: 14726411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of the lipid-protein interaction in human low-density lipoprotein destabilizes ApoB-100 and decreases oxidizability.
    Abuja PM; Lohner K; Prassl R
    Biochemistry; 1999 Mar; 38(11):3401-8. PubMed ID: 10079085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major apolipoprotein B-100 mutations in lipoprotein metabolism and atherosclerosis.
    Vrablík M; Ceska R; Horínek A
    Physiol Res; 2001; 50(4):337-43. PubMed ID: 11551138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and functional properties of apolipoprotein B in chemically modified low density lipoproteins.
    Vanderyse L; Devreese AM; Baert J; Vanloo B; Lins L; Ruysschaert JM; Rosseneu M
    Atherosclerosis; 1992 Dec; 97(2-3):187-99. PubMed ID: 1466663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.
    Skålén K; Gustafsson M; Rydberg EK; Hultén LM; Wiklund O; Innerarity TL; Borén J
    Nature; 2002 Jun; 417(6890):750-4. PubMed ID: 12066187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small dense low density lipoprotein: formation and potential mechanisms for atherogenicity.
    Deckelbaum RJ; Galeano NF
    Isr J Med Sci; 1996 Jun; 32(6):464-8. PubMed ID: 8682652
    [No Abstract]   [Full Text] [Related]  

  • 15. Estradiol enhances the resistance of LDL to oxidation by stabilizing apoB-100 conformation.
    Brunelli R; Mei G; Krasnowska EK; Pierucci F; Zichella L; Ursini F; Parasassi T
    Biochemistry; 2000 Nov; 39(45):13897-903. PubMed ID: 11076531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of apolipoprotein B-100 in low density lipoproteins.
    Segrest JP; Jones MK; De Loof H; Dashti N
    J Lipid Res; 2001 Sep; 42(9):1346-67. PubMed ID: 11518754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative crosslinking of LDL protein induced by hemin: involvement of tyrosines.
    Miller YI; Shaklai N
    Biochem Mol Biol Int; 1994 Dec; 34(6):1121-9. PubMed ID: 7696984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidation of apolipoprotein B-100 in circulating LDL is related to LDL residence time. In vivo insights from stable-isotope studies.
    Pietzsch J; Lattke P; Julius U
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):E63-7. PubMed ID: 11031225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis.
    Uchida K; Toyokuni S; Nishikawa K; Kawakishi S; Oda H; Hiai H; Stadtman ER
    Biochemistry; 1994 Oct; 33(41):12487-94. PubMed ID: 7918471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oxidation on the structure and stability of human low-density lipoprotein.
    Jayaraman S; Gantz DL; Gursky O
    Biochemistry; 2007 May; 46(19):5790-7. PubMed ID: 17444660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.